Active Care Family Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 212 Main St, Stevensville, MT 59870 Phone: 406-777-1048 |
Dr. Amy Berglund, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 212 Main St, Stevensville, MT 59870 Phone: 406-777-1048 Fax: 406-777-1038 |
Better Root Health Chiropractic, Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 3920 Us Highway 93 N Ste D, Stevensville, MT 59870 Phone: 406-777-7172 Fax: 406-777-7266 |
Dr. Keith B Berning, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3920 Us Highway 93 N, Ste D, Stevensville, MT 59870 Phone: 406-777-7172 Fax: 406-777-7266 |
Chase James Crabtree, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 212 Main St, Stevensville, MT 59870 Phone: 406-777-1048 Fax: 406-777-1038 |
Dr. William J Mcnulty, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 3946 Us Hwy 93 S, Stevensville, MT 59870 Phone: 406-777-5630 Fax: 406-777-0061 |
Dr. Don S Finley, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 419 Main Street, Stevensville, MT 59870 Phone: 406-777-2926 Fax: 406-777-2648 |
Dr. Emily Rausch, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 212 Main St, Stevensville, MT 59870 Phone: 406-777-1048 Fax: 406-777-1038 |
News Archive
Biotechnology Industry Organization Industry Analysis and BioMedTracker announced results of a study today that shows the overall success rate for drugs moving through clinical trials to FDA approval from late 2003 to the end of 2010 is near one in 10. Previous reports, taken from earlier years, showed the rate of drug approvals is one in five to one in six.
Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's.
The Obesity Society (TOS) took the next step to advance the treatment of obesity by publishing an unprecedented level of obesity research, in print and online, as a supplement to its July and August issues of the Obesity journal: Guidelines (2013) for Managing Overweight and Obesity in Adults: Full Report. Now, the print version of the supplement is available for purchase as a reference guide for obesity treatment.
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
› Verified 9 days ago